Biotech · Private company
Complement Therapeutics
Track this companyFree. Adds Complement Therapeutics to your Dealase workspace and tells you when its record changes.
Clinical trials32 recruiting or active
Pipeline programs1From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline1
- CTx001Phase 2 · Geographic Atrophy Secondary to Age-related Macular DegenerationClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- An Optimised GA Interventional Trial (Opti-GAIN) to Test if Treatment With CTx001 is Safe and Works for People With Geographic Atrophy (GA)PHASE1_PHASE2 · RECRUITING · started Dec 30, 2025ClinicalTrials.gov NCT07392255 · fetched Nov 12, 2026
- A Non-Interventional Study Observing Short-Term Progression in Geographic Atrophy (GA)RECRUITING · started Jul 30, 2025ClinicalTrials.gov NCT07144137 · fetched Nov 12, 2026
- Investigating Geographic Atrophy Insights (i-GAIN) Natural History StudyCOMPLETED · started Feb 7, 2023ClinicalTrials.gov NCT05797896 · fetched Nov 12, 2026